A phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN): SWOG study S0329

od Malhotra, Binu, Moon, James, Kucuk, Omar, Clark, Joseph I, Urba, Susan G, Wolf, Gregory T, Worden, Francis P
Izdano u Head Neck (2014)

Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420

od Williamson, Stephen K., Moon, James, Huang, Chao H., Guaglianone, Perry P., LeBlanc, Michael, Wolf, Gregory T., Urba, Susan G.
Izdano 2010

Docetaxel, cisplatin and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced sq...

od Adelstein, David J., Moon, James, Hanna, Ehab, Giri, P.G. Shankar, Mills, Glenn M., Wolf, Gregory T., Urba, Susan G.
Izdano 2010

Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S...

od Arnold, Susanne M., Moon, James, Williamson, Stephen K., Atkins, James N., Ou, Sai-Hong I., LeBlanc, Michael, Urba, Susan G.
Izdano 2009

Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: A study based on SWOG protocol S0420

od MEHTA, SMITA, MOON, JAMES, HASHMI, MEHMOOD, LEBLANC, MICHAEL, HUANG, CHAO HUI, RINEHART, ELIZABETH, WOLF, GREGORY T., URBA, SUSAN G., BANERJEE, SUSHANTA K., WILLIAMSON, STEPHEN
Izdano 2013

A PHASE II TRIAL OF SURGERY WITH PERIOPERATIVE INGN 201 (Ad5CMV-p53) GENE THERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR ADVANCED, RESECTABLE SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY,...

od Yoo, George H., Moon, James, LeBlanc, Michael, Lonardo, Fulvio, Urba, Susan, Kim, Harold, Hanna, Ehab, Tsue, Terry, Valentino, Joseph, Ensley, John, Wolf, Gregory
Izdano 2009

Circulating CD4-positive lymphocyte levels predict response to induction chemotherapy in patients with advanced laryngeal cancer

od Dewyer, Nicholas A., Wolf, Gregory T., Light, Emily, Worden, Francis, Urba, Susan, Eisbruch, Avraham, Bradford, Carol R., Chepeha, Douglas B., Prince, Mark E., Moyer, Jeffrey, Taylor, Jeremy
Izdano u Head Neck (2013)

Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer

od Schneider, Bryan J., Lee, Julia Shin-Jung, Hayman, James A., Chang, Andrew C., Orringer, Mark B., Pickens, Allan, Pan, Charlie C., Merajver, Sofia D., Urba, Susan G.
Izdano u Invest New Drugs (2012)

Classification of TP53 Mutations and HPV Predict Survival in Advanced Larynx Cancer

od Scheel, Adam, Bellile, Emily, McHugh, Jonathan B., Walline, Heather M., Prince, Mark E., Urba, Susan, Wolf, Gregory T., Eisbruch, Avraham, Worden, Francis, Carey, Thomas E., Bradford, Carol
Izdano u Laryngoscope (2016)

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

od Samuels, Stuart E., Stenmark, Matthew H., Lee, Jae Y., McHugh, Jonathan B., Hayman, James A., Orringer, Mark B., Urba, Susan G., Sun, Libin, Xie, Congying, Kong, Feng-Ming, Cuneo, Kyle C.
Izdano u Adv Radiat Oncol (2017)

Chemotherapy alone for organ preservation in advanced laryngeal cancer

od Divi, Vasu, Worden, Francis P., Prince, Mark E., Eisbruch, Avraham, Lee, Julia S., Bradford, Carol R., Chepeha, Douglas B., Teknos, Theodoros N., Hogikyan, Norman D., Moyer, Jeffrey S., Tsien, Christina I., Urba, Susan G., Wolf, Gregory T.
Izdano 2010

INFILTRATING LYMPHOCYTES AND HUMAN PAPILLOMAVIRUS-16 ASSOCIATED OROPHARYNX CANCER

od Wansom, Derrick, Light, Emily, Thomas, Dafydd, Worden, Francis, Prince, Mark, Urba, Susan, Chepeha, Douglas, Kumar, Bhavna, Cordell, Kitrina, Eisbruch, Avraham, Taylor, Jeremy, Moyer, Jeffrey, Bradford, Carol, D’Silva, Nisha, Carey, Thomas, McHugh, Jonathan, Wolf, Gregory
Izdano 2012

Correlation of Cellular Immunity with Human Papillomavirus 16 Status and Outcome in Patients with Advanced Oropharyngeal Cancer

od Wansom, Derrick, Light, Emily, Worden, Frank, Prince, Mark, Urba, Susan, Chepeha, Douglas B, Cordell, Kitrina, Eisbruch, Avraham, Taylor, Jeremy, D’Silva, Nisha, Moyer, Jeffrey, Bradford, Carol R, Kurnit, David, Kumar, Bhavna, Carey, Thomas E, Wolf, Gregory T
Izdano 2010

Survival Rates Using Individualized Bioselection Treatment Methods in Patients with Advanced Laryngeal Cancer : The University of Michigan Experience

od Wolf, Gregory T., Bellile, Emily, Eisbruch, Avraham, Urba, Susan, Bradford, Carol R., Peterson, Lisa, Prince, Mark E., Teknos, Theodoros N., Chepeha, Douglas B., Hogikyan, Norman D., McLean, Scott A., Moyer, Jeffery, Taylor, Jeremy MG, Worden, Francis P.
Izdano u JAMA Otolaryngol Head Neck Surg (2017)

Induction chemotherapy followed by chemoradiation for organ preservation compared to surgery with selective chemoradiation in patients with advanced oral cavity carcinoma

od Chinn, Steven B., Spector, Matthew E., Bellile, Emily L., Rozek, Laura S., Lin, Tasha, Teknos, Theodoros N., Prince, Mark E., Bradford, Carol R., Urba, Susan G., Carey, Thomas E., Eisbruch, Avraham, Wolf, Gregory T., Worden, Francis P., Chepeha, Douglas B.
Izdano 2014

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

od Sohal, Davendra P.S., Mangu, Pamela B., Khorana, Alok A., Shah, Manish A., Philip, Philip A., O’Reilly, Eileen M., Uronis, Hope E., Ramanathan, Ramesh K., Crane, Christopher H., Engebretson, Anitra, Ruggiero, Joseph T., Copur, Mehmet S., Lau, Michelle, Urba, Susan, Laheru, Daniel
Izdano u J Clin Oncol (2016)

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer

od LaBonte, Melissa J., Yang, Dongyun, Zhang, Wu, Wilson, Peter M., Nagarwala, Yasir M., Koch, Kevin M., Briner, Colleen, Kaneko, Tomomi, Rha, Sun-Young, Gladkov, Oleg, Urba, Susan G., Sakaeva, Dina, Pishvaian, Michael J., Hsieh, Ruey-Kuen, Lee, Wei-Ping, Lenz, Heinz-Josef
Izdano u Mol Cancer Ther (2016)

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update

od Sohal, Davendra P.S., Kennedy, Erin B., Khorana, Alok, Copur, Mehmet S., Crane, Christopher H., Garrido-Laguna, Ignacio, Krishnamurthi, Smitha, Moravek, Cassadie, O’Reilly, Eileen M., Philip, Philip A., Ramanathan, Ramesh K., Ruggiero, Joseph T., Shah, Manish A., Urba, Susan, Uronis, Hope E., Lau, Michelle W., Laheru, Daniel
Izdano u J Clin Oncol (2018)

Biomarkers in Advanced Larynx Cancer

od Bradford, Carol R., Kumar, Bhavna, Bellile, Emily, Lee, Julia, Taylor, Jeremy, D’Silva, Nisha, Cordell, Kitrina, Kleer, Celina, Kupfer, Robbi, Kumar, Pawan, Urba, Susan, Worden, Francis, Eisbruch, Avraham, Wolf, Gregory T., Teknos, Theodoros N., Prince, Mark E.P., Chepeha, Douglas B., Hogikyan, Norman D., Moyer, Jeffrey S., Carey, Thomas E.
Izdano 2013

Response to Therapy and Outcome in Oropharyngeal Cancer are Associated with Biomarkers Including HPV, EGFR, Gender and Smoking

od Kumar, Bhavna, Cordell, Kitrina G., Lee, Julia S., Prince, Mark E., Tran, Huong H., Wolf, Gregory T., Urba, Susan G., Worden, Francis P., Chepeha, Douglas B., Teknos, Theodoros N., Eisbruch, Avraham, Tsien, Christina I., Taylor, Jeremy M.G., D'Silva, Nisha J., Yang, Kun, Kurnit, David M., Bradford, Carol R., Carey, Thomas E.
Izdano 2007